HIGH-DOSE ARA-C WITH ASPARAGINASE (A'ASE) IN THE TREATMENT OF REFRACTORY LEUKEMIA

被引:0
|
作者
CAPIZZI, RL [1 ]
GRIFFIN, F [1 ]
CHENG, YC [1 ]
BAILEY, K [1 ]
RUDNICK, SA [1 ]
机构
[1] UNIV N CAROLINA,CHAPEL HILL,NC 27514
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:148 / 148
页数:1
相关论文
共 50 条
  • [41] High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia:: a pharmacokinetic and clinical study
    Tedeschi, Alessandra
    Montillo, Marco
    Strocchi, Elena
    Cafro, Anna Maria
    Tresoldi, Elisabetta
    Intropido, Liliana
    Nichelatti, Michele
    Marbello, Laura
    Barate, Claudia
    Camaggi, Carlo Maurizio
    Morra, Enrica
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (06) : 771 - 779
  • [42] High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study
    Alessandra Tedeschi
    Marco Montillo
    Elena Strocchi
    Anna Maria Cafro
    Elisabetta Tresoldi
    Liliana Intropido
    Michele Nichelatti
    Laura Marbello
    Claudia Baratè
    Carlo Maurizio Camaggi
    Enrica Morra
    Cancer Chemotherapy and Pharmacology, 2007, 59 : 771 - 779
  • [43] A Randomized Comparison of Modified Intermediate-dose Ara-C versus High-dose Ara-C in Post-remission Therapy for Acute Myeloid Leukemia
    Fukushima, Toshihiro
    Urasaki, Yoshimasa
    Yamaguchi, Masaki
    Ueda, Mikio
    Morinaga, Koji
    Haba, Toshihiro
    Sugiyama, Toshiro
    Nakao, Shinji
    Origasa, Hideki
    Umehara, Hisanori
    Ueda, Takanori
    ANTICANCER RESEARCH, 2012, 32 (02) : 643 - 647
  • [44] RELATIONSHIP OF [H-3] ARA-C INCORPORATION AND RESPONSE TO THERAPY WITH HIGH-DOSE ARA-C IN AML PATIENTS - A LEUKEMIA INTERGROUP STUDY
    RAZA, A
    GEZER, S
    ANDERSON, J
    LYKINS, J
    BENNETT, J
    BROWMAN, G
    GOLDBERG, J
    LARSON, R
    VOGLER, R
    PREISLER, HD
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (10) : 1194 - 1200
  • [45] RELATIONSHIP BETWEEN PLASMA ARA-C AND INTRACELLULAR ARA-CTP POOLS UNDER CONDITIONS OF CONTINUOUS INFUSION AND HIGH-DOSE ARA-C TREATMENT
    RUSTUM, YM
    SLOCUM, HK
    WANG, G
    BAKSHI, D
    KELLY, E
    BUSCAGLIA, D
    WRZOSEK, C
    EARLY, AP
    PREISLER, H
    MEDICAL AND PEDIATRIC ONCOLOGY, 1982, : 33 - 43
  • [46] ACUTE CEREBELLAR DYSFUNCTION WITH HIGH-DOSE ARA-C THERAPY
    SALINSKY, MC
    LEVINE, RL
    AUBUCHON, JP
    SCHUTTA, HS
    CANCER, 1983, 51 (03) : 426 - 429
  • [47] SATURATION OF ARA-CTP ACCUMULATION DURING HIGH-DOSE ARA-C THERAPY - PHARMACOLOGICAL RATIONALE FOR INTERMEDIATE-DOSE ARA-C
    PLUNKETT, W
    LILIEMARK, JO
    ESTEY, E
    KEATING, MJ
    SEMINARS IN ONCOLOGY, 1987, 14 (02) : 159 - 166
  • [48] CELL KINETIC ASPECTS OF HIGH-DOSE THERAPY WITH ARA-C
    SMETS, LA
    CYTOMETRY, 1981, 2 (02): : 128 - 128
  • [49] PHARMACOKINETICS OF HIGH-DOSE CYTOSINE-ARABINOSIDE (ARA-C)
    HANDE, KR
    STEIN, RS
    MCDONOUGH, DA
    WOLFF, SN
    CLINICAL RESEARCH, 1981, 29 (02): : A436 - A436
  • [50] PERIPHERAL NEUROPATHY ASSOCIATED WITH HIGH-DOSE ARA-C THERAPY
    BORGEAT, A
    DEMURALT, B
    STALDER, M
    CANCER, 1986, 58 (04) : 852 - 854